Alessio Molfino, Emanuela Anastasi, Eleonora Assanto, Ludovica Toccini, Giovanni Imbimbo, Antonietta Gigante, Valentina Viggiani, Antonella Farina, Orietta Picconi, Antonio Angeloni, Maurizio Muscaritoli
To quantify the circulating levels of novel serum biomarkers including GDF-15, PIVKA-II, sdLDL, suPAR, and of CRP in hospitalized COVID-19 patients compared with healthy subjects, and to evaluate their association(s) with outcomes in COVID-19. We considered patients with confirmed COVID-19, hospitalized in an Internal Medicine ward. The clinical characteristics were collected, including the number and type of comorbidities. Serum levels of GDF-15, PIVKA-II, suPAR, sdLDL, as well as CRP were measured. As outcomes, we considered Intensive Care Unit (ICU) transfer or death, as well as the length of stay (days) and in-hospital complications...
May 3, 2024: Internal and Emergency Medicine